oseltamivir
Antiinfectives for systemic use (J05)Antiinfectives for systemic use (J05) compound in Tongji Hospital's portfolio.
pharma · 2019-nCoV Pneumonia
Tongji Hospital
Tongji Hospital drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Tongji Hospital pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Tongji Hospital drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.